Interleukin-18 and Dendritic Cells in Psoriasis
Author Information
Author(s): Aldona Pietrzak, Konrad Janowski, Grażyna Chodorowska, Anna Michalak-Stoma, Jacek Roliński, Anna Zalewska, Iwona Jastrzębska, Jacek Tabarkiewicz, Tomasz Paszkowski, Ewa Kapeć, Dorota Krasowska
Primary Institution: Medical University of Lublin
Hypothesis
The study investigates the relationship between plasma interleukin-18 (IL-18) levels and blood dendritic cells in psoriatic patients.
Conclusion
The study found that plasma IL-18 levels were significantly higher in males with psoriasis, while counts of certain dendritic cells were lower compared to healthy controls.
Supporting Evidence
- IL-18 plasma levels were significantly higher in psoriatic males compared to healthy controls.
- Counts of BDCA-2+ cells were significantly lower in patients with psoriasis than in healthy controls.
- Significant negative correlations were found between plasma IL-18 levels and counts of BDCA-1+ and BDCA-2+ cells.
Takeaway
This study looked at how a substance called IL-18 in the blood affects special immune cells in men with a skin condition called psoriasis.
Methodology
The study measured plasma IL-18 levels using ELISA and analyzed dendritic cell subsets using flow cytometry.
Limitations
The study only included male participants, which may limit the generalizability of the findings.
Participant Demographics
Thirty-eight males with psoriasis and 21 healthy male volunteers participated in the study.
Statistical Information
P-Value
0.027
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website